Skip to main content
Kenneth Westover, MD, Radiation Oncology, Dallas, TX, University of Texas Southwestern Medical Center

KennethDWestoverMDPhD

Radiation Oncology Dallas, TX

Associate Professor of Radiation Oncology and Biochemistry Director of Clinical Innovation, UT Southwestern Medical Center

Dr. Westover is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Westover's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2008 - 2012
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2007 - 2008
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2007
  • Stanford University
    Stanford UniversityPh.D., Biophysics, 2005
  • Brigham Young University
    Brigham Young UniversityBS, Biochemistry, 1999

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2012 - 2024
  • MA State Medical License
    MA State Medical License 2008 - 2013
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • V Scholar V Foundation for Cancer Research, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Finalist, Damon Runyon Innovator Award 2012
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Consolidative Radiotherapy for Limited Metastatic Non�Small-Cell Lung CancerA Phase 2 Randomized Clinical Trial  
    Iyengar P, Wardak Z, Gerber DE, Tumati V, Ahn C, Hughes RS, Dowell JE, Cheedella N, Nedzi L, Westover KD, Pulipparacharuvil S, Choy H, Timmerman RD., JAMA Oncol., 1/1/2018
  • A pilot study using kernelled support tensor machine for distant failure prediction in lung SBRT  
    Li S, Yang N, Li B, Zhou Z, Hao H, Folkert MR, Iyengar P, Westover K, Choy H, Timmerman R, Jiang S, Wang J., Med Image Anal., 1/1/2018
  • Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer  
    Hao H, Zhou Z, Li S, Maquilan G, Folkert MR, Iyengar P, Westover KD, Albuquerque K, Liu F, Choy H, Timmerman R, Yang L, Wang J, Medical Physics, 1/1/2017
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Safety Analysis From a Prospective Registry Study of Stereotactic Body Radiation Therapy for Aggressive Management of Late-Stage Disease.
    Maquilan G, Westover KD, Wardak Z, Timmerman RD, Hannan R, Iyengar P, Schwartz DL, Meyer JJ, Abdulrahman RE, Folkert MR, Laine AM, Desai NB, Albuquerque KV, Choy H, Ah..., Int J Radiat Oncol Biol Phys., 1/1/2016
  • Distinctive structural dynamics in Ras and related proteins by hydrogen exchange mass spectrometry
    Harrison R, Carrasco M, Hunter J, Manandhar A, Westover KD, Engen J., 63rd Annual Meeting, American Society for Mass Spectrometry, 1/1/2015
  • Outcomes of proton beam based SBRT in medically inoperable stage I NSCLC
    Westover KD, Engelsman M, Adams J, Lanuti M, Choi N, Willers H., 53rd Annual Meeting American Society for Radiation Oncology, 1/1/2011
  • Join now to see all

Lectures

  • Targeting RAS in an Allele-Specific Manner 
    First Affiliated Hospital of Chengdu Medical College, Chengdu, China - 1/1/2018
  • Allele-Specific Approaches to targeting RAS 
    San Francisco, CA - 1/1/2018
  • KRAS Q61H signals in a RAF dimer-dependent manner 
    San Diego, CA - 1/1/2018
  • Join now to see all

Press Mentions

  • Simmons Cancer Center Investigators Receive More Than $17 Million in CPRIT Funding
    Simmons Cancer Center Investigators Receive More Than $17 Million in CPRIT FundingJune 8th, 2022
  • UTSW Findings Advance RAS Inhibitors for Use in Fighting More Cancers
    UTSW Findings Advance RAS Inhibitors for Use in Fighting More CancersNovember 4th, 2021
  • Discovery Suggests New Strategy for Attacking High- Profile but Elusive Target in Cancer
    Discovery Suggests New Strategy for Attacking High- Profile but Elusive Target in CancerJanuary 12th, 2018
  • Join now to see all

Hospital Affiliations